Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Debt-to-Equity

: 1.40 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

Gulf Pharmaceutical Industries PSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was د.إ254 Mil. Gulf Pharmaceutical Industries PSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was د.إ857 Mil. Gulf Pharmaceutical Industries PSC's Total Stockholders Equity for the quarter that ended in Dec. 2023 was د.إ794 Mil. Gulf Pharmaceutical Industries PSC's debt to equity for the quarter that ended in Dec. 2023 was 1.40.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Debt-to-Equity or its related term are showing as below:

ADX:JULPHAR' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.34 Med: 0.67 Max: 1.4
Current: 1.4

During the past 13 years, the highest Debt-to-Equity Ratio of Gulf Pharmaceutical Industries PSC was 1.40. The lowest was 0.34. And the median was 0.67.

ADX:JULPHAR's Debt-to-Equity is ranked worse than
92.85% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs ADX:JULPHAR: 1.40

Gulf Pharmaceutical Industries PSC Debt-to-Equity Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

1.29

0.68

0.86

0.97

1.40

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.97	1.05	1.25	1.38	1.40

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gulf Pharmaceutical Industries PSC Debt-to-Equity Distribution

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Debt-to-Equity falls into.

Gulf Pharmaceutical Industries PSC Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Gulf Pharmaceutical Industries PSC's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(254	+	856.6)	/	794.2
	=	1.40

Gulf Pharmaceutical Industries PSC's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(254	+	856.6)	/	794.2
	=	1.40

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Gulf Pharmaceutical Industries PSC Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines